HBV/HCV/HIV serology pre-rituximab. NLPBL not associated with EBV (unlike classical Hodgk...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-NLPBL-INFECTION-SCREENING |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-NLPBL |
| Sources | SRC-ESMO-HODGKIN-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | HBV/HCV/HIV serology pre-rituximab. NLPBL not associated with EBV (unlike classical Hodgkin); serology routine, not diagnostic. |
|---|---|
| Clinical direction | investigate |
| Category | infection-screening |
Trigger Logic
{
"any_of": [
{
"finding": "hbsag",
"value": "positive"
},
{
"finding": "anti_hcv",
"value": "positive"
},
{
"finding": "hiv_serology",
"value": "positive"
}
],
"type": "biomarker"
}
Notes
Standard pre-anti-CD20 screening; HBV reactivation handled by universal RF.
Used By
No reverse references found in the YAML corpus.